AI assistant
Sending…
ULTRALIFE CORP — Director's Dealing 2025
May 14, 2025
34105_dirs_2025-05-14_4c44ff2a-16f9-47d3-8418-6d7d8a6d1a66.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2025-05-13
Reporting Person: Saeli Thomas Louis (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-14 | Common Stock; $.10 par value | P | 5000 | $5.44 | Acquired | 85000 | Direct |
Footnotes
F1: 5,000 shares purchased at an average cost of $5.4400 per share as follows: 2,995 shares purchased on May 13, 2025 at a cost of $5.4316 per share and 2,005 shares purchased on May 14, 2025 at a cost of $5.4525.
More from ULTRALIFE CORP
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 29
Annual Report
2026
Mar 23
Major Shareholding Notification
2026
Mar 17
Regulatory Filings
2026
Mar 16
Regulatory Filings
2026
Mar 10
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Jan 5
Director's Dealing
2025
Dec 16